BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $288,145 | -17.2% | 7,635 | 0.0% | 0.07% | -9.9% |
| Q2 2023 | $347,851 | -64.8% | 7,635 | -68.7% | 0.08% | -66.9% |
| Q1 2023 | $988,042 | -20.4% | 24,360 | 0.0% | 0.24% | -29.2% |
| Q4 2022 | $1,241,629 | -9.1% | 24,360 | -3.9% | 0.35% | -11.1% |
| Q3 2022 | $1,366,000 | -18.0% | 25,360 | -2.2% | 0.39% | -13.7% |
| Q2 2022 | $1,666,000 | -17.2% | 25,940 | 0.0% | 0.45% | +0.7% |
| Q1 2022 | $2,011,000 | -9.7% | 25,940 | 0.0% | 0.45% | -5.9% |
| Q4 2021 | $2,227,000 | +6.8% | 25,940 | 0.0% | 0.48% | -8.3% |
| Q3 2021 | $2,086,000 | -0.1% | 25,940 | 0.0% | 0.52% | +1.2% |
| Q2 2021 | $2,088,000 | -4.6% | 25,940 | 0.0% | 0.51% | -11.6% |
| Q1 2021 | $2,188,000 | +5.1% | 25,940 | 0.0% | 0.58% | +5.5% |
| Q4 2020 | $2,081,000 | -0.2% | 25,940 | 0.0% | 0.55% | -9.4% |
| Q3 2020 | $2,086,000 | -6.6% | 25,940 | 0.0% | 0.61% | -19.4% |
| Q2 2020 | $2,233,000 | +6.0% | 25,940 | 0.0% | 0.75% | -13.8% |
| Q1 2020 | $2,106,000 | -4.0% | 25,940 | -1.1% | 0.87% | +20.4% |
| Q4 2019 | $2,194,000 | -9.6% | 26,240 | -5.4% | 0.73% | -20.3% |
| Q3 2019 | $2,426,000 | -0.2% | 27,740 | -6.6% | 0.91% | -2.9% |
| Q2 2019 | $2,432,000 | +0.7% | 29,700 | 0.0% | 0.94% | -0.4% |
| Q1 2019 | $2,414,000 | +17.6% | 29,700 | -4.8% | 0.94% | +5.8% |
| Q4 2018 | $2,053,000 | -16.2% | 31,200 | -1.9% | 0.89% | +3.0% |
| Q3 2018 | $2,451,000 | +4.4% | 31,800 | 0.0% | 0.86% | -6.3% |
| Q2 2018 | $2,348,000 | +12.1% | 31,800 | -1.2% | 0.92% | +10.4% |
| Q1 2018 | $2,094,000 | +0.6% | 32,200 | 0.0% | 0.84% | +3.1% |
| Q4 2017 | $2,081,000 | +2.4% | 32,200 | -0.6% | 0.81% | -4.3% |
| Q3 2017 | $2,033,000 | +2.1% | 32,400 | -1.5% | 0.85% | -1.7% |
| Q2 2017 | $1,991,000 | +7.0% | 32,900 | -8.4% | 0.86% | +8.7% |
| Q1 2017 | $1,861,000 | +17.0% | 35,900 | 0.0% | 0.79% | +7.6% |
| Q4 2016 | $1,591,000 | -10.6% | 35,900 | -4.0% | 0.74% | -10.6% |
| Q3 2016 | $1,780,000 | +5.3% | 37,400 | 0.0% | 0.82% | +0.5% |
| Q2 2016 | $1,691,000 | +8.7% | 37,400 | -1.3% | 0.82% | +9.2% |
| Q1 2016 | $1,556,000 | +4.9% | 37,900 | -2.6% | 0.75% | +4.6% |
| Q4 2015 | $1,484,000 | +16.2% | 38,900 | 0.0% | 0.72% | +12.9% |
| Q3 2015 | $1,277,000 | -53.1% | 38,900 | 0.0% | 0.64% | -48.4% |
| Q2 2015 | $2,720,000 | +2.1% | 38,900 | 0.0% | 1.23% | +1.8% |
| Q1 2015 | $2,664,000 | -11.6% | 38,900 | -5.4% | 1.21% | -9.0% |
| Q4 2014 | $3,012,000 | +2.1% | 41,100 | 0.0% | 1.33% | 0.0% |
| Q3 2014 | $2,949,000 | -0.7% | 41,100 | 0.0% | 1.33% | -1.4% |
| Q2 2014 | $2,971,000 | -5.4% | 41,100 | -3.7% | 1.35% | -10.9% |
| Q1 2014 | $3,141,000 | +3.1% | 42,700 | -2.5% | 1.51% | +2.9% |
| Q4 2013 | $3,046,000 | +5.9% | 43,800 | 0.0% | 1.47% | -3.2% |
| Q3 2013 | $2,877,000 | – | 43,800 | – | 1.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |